Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parecoxib: a shift in pain management?

Anthony S Dalpiaz1, Dave Peterson

  • 1Department of Pharmacy Services, University of Utah Hospitals and Clinics, 50 North Medical Drive, Salt Lake City, UT 84132, USA. Anthony.Dalpiaz@hsc.utah.edu

Expert Review of Neurotherapeutics
|April 28, 2005
PubMed
Summary

Parecoxib, a parenteral cyclooxygenase-2 inhibitor, effectively reduces post-surgical pain and opioid use. It demonstrates a favorable gastrointestinal safety profile compared to ketorolac, with no adverse effects on platelet function or coagulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Agrobacterium transformation and vector design result in high-frequency targeted gene insertion in maize.

Plant biotechnology journal·2021
Same author

Complex Trait Loci in Maize Enabled by CRISPR-Cas9 Mediated Gene Insertion.

Frontiers in plant science·2020
Same author

Superior field performance of waxy corn engineered using CRISPR-Cas9.

Nature biotechnology·2020
Same author

Uniform Expression and Relatively Small Position Effects Characterize Sister Transformants in Maize and Soybean.

Frontiers in plant science·2019
Same author

Spinal manipulation and exercise for low back pain in adolescents: study protocol for a randomized controlled trial.

Chiropractic & manual therapies·2014
Same author

Development and psychometric evaluation of an evidence-based practice questionnaire for a chiropractic curriculum.

Journal of manipulative and physiological therapeutics·2012

Area of Science:

  • Pharmacology
  • Anesthesiology
  • Gastroenterology

Background:

  • Parecoxib is a parenteral cyclooxygenase-2 (COX-2) inhibitor approved in Europe.
  • Post-surgical pain management remains a critical aspect of patient recovery.

Purpose of the Study:

  • To evaluate the efficacy and safety of parecoxib in managing post-surgical pain.
  • To assess parecoxib's impact on opioid consumption and gastrointestinal side effects.

Main Methods:

  • Systematic review of clinical trials investigating parecoxib for post-surgical pain.
  • Analysis of efficacy, opioid-sparing effects, and gastrointestinal and coagulation profiles.

Main Results:

  • Parecoxib demonstrated dose-related efficacy in reducing pain after various surgeries, comparable to ketorolac.

Related Experiment Videos

  • An opioid-sparing effect was observed with parecoxib.
  • Fewer gastroduodenal ulcers and erosions occurred with parecoxib compared to ketorolac.
  • Parecoxib did not negatively impact platelet aggregation or coagulation parameters.

    • Conclusions:

    • Parecoxib is an effective parenteral COX-2 inhibitor for post-surgical pain management.
    • It offers a potential alternative to ketorolac with a potentially improved gastrointestinal safety profile.
    • Its lack of interference with platelet function and coagulation makes it a safe option in various surgical settings.